These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 32009066

  • 1. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T, Nagai T, Watanabe M, Kamada R, Takahashi Y, Hagiwara H, Koya T, Nakao M, Omote K, Kamiya K, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
    Circ J; 2020 Feb 25; 84(3):397-403. PubMed ID: 32009066
    [Abstract] [Full Text] [Related]

  • 2. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK, Park JJ, Lim NK, Kim WH, Choi DJ.
    Heart; 2020 Aug 25; 106(15):1160-1168. PubMed ID: 32341140
    [Abstract] [Full Text] [Related]

  • 3. Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.
    Schupp T, Schmitt A, Reinhardt M, Abel N, Lau F, Abumayyaleh M, Dudda J, Weidner K, Ayoub M, Akin M, Müller J, Akin I, Behnes M.
    Eur J Prev Cardiol; 2024 Aug 22; 31(11):1372-1384. PubMed ID: 38825871
    [Abstract] [Full Text] [Related]

  • 4. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U, Dahlström U, Fu M, Lund LH.
    JACC Heart Fail; 2017 Aug 22; 5(8):565-574. PubMed ID: 28711451
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of atrial fibrillation progression in patients with heart failure with preserved ejection fraction: A report from the CHART-2 Study.
    Ito T, Noda T, Nochioka K, Shiroto T, Yamamoto N, Sato H, Chiba T, Hasebe Y, Nakano M, Takahama H, Takahashi J, Miyata S, Shimokawa H, Yasuda S.
    Europace; 2024 Aug 30; 26(9):. PubMed ID: 39150084
    [Abstract] [Full Text] [Related]

  • 6. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF.
    J Cardiovasc Electrophysiol; 2024 Apr 30; 35(4):715-726. PubMed ID: 38348517
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.
    Jobs A, Schwind J, Katalinic A, Babaev V, Tilz RR, Rausch S, Thiele H, Eitel I, Eitel C.
    Clin Res Cardiol; 2019 Jan 30; 108(1):74-82. PubMed ID: 29987595
    [Abstract] [Full Text] [Related]

  • 8. Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction　- A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry.
    Nagai T, Yoshikawa T, Saito Y, Takeishi Y, Yamamoto K, Ogawa H, Anzai T, JASPER Investigators.
    Circ J; 2018 May 25; 82(6):1534-1545. PubMed ID: 29576598
    [Abstract] [Full Text] [Related]

  • 9. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A, Tanino T, Yamaguchi T, Hirota K, Saito S, Okada N, Akioka H, Shinohara T, Yufu K, Takahashi N.
    J Cardiovasc Electrophysiol; 2020 Mar 25; 31(3):682-688. PubMed ID: 31985099
    [Abstract] [Full Text] [Related]

  • 10. Effect of Obesity on the Prognostic Impact of Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction.
    Yagawa M, Nagatomo Y, Izumi Y, Mahara K, Tomoike H, Shiraishi Y, Kohno T, Mizuno A, Goda A, Kohsaka S, Yoshikawa T, West Tokyo Heart Failure (WET-HF) Registry Collaborative Group.
    Circ J; 2017 Jun 23; 81(7):966-973. PubMed ID: 28367843
    [Abstract] [Full Text] [Related]

  • 11. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry.
    Özlek B, Özlek E, Tekinalp M, Kahraman S, Zencirkiran Agus H, Başaran Ö, Kaya BC, Rencüzoğulları İ, Mert KU, Çakır O, Ösken A, Bekar L, Çelik Y, Çil C, Doğan V, Çelik O, Mert GÖ, Memiç Sancar K, Sevinç S, Biteker M.
    Turk Kardiyol Dern Ars; 2020 Apr 23; 48(3):234-245. PubMed ID: 32281959
    [Abstract] [Full Text] [Related]

  • 12. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
    Sartipy U, Savarese G, Dahlström U, Fu M, Lund LH.
    Eur J Heart Fail; 2019 Apr 23; 21(4):471-479. PubMed ID: 30698317
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Importance of Right Ventricular-Vascular Uncoupling in Acute Decompensated Heart Failure With Preserved Ejection Fraction.
    Nakagawa A, Yasumura Y, Yoshida C, Okumura T, Tateishi J, Yoshida J, Abe H, Tamaki S, Yano M, Hayashi T, Nakagawa Y, Yamada T, Nakatani D, Hikoso S, Sakata Y.
    Circ Cardiovasc Imaging; 2020 Nov 23; 13(11):e011430. PubMed ID: 33198494
    [Abstract] [Full Text] [Related]

  • 14. Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.
    Zhang M, Zhou J.
    BMC Cardiovasc Disord; 2024 Sep 18; 24(1):495. PubMed ID: 39289613
    [Abstract] [Full Text] [Related]

  • 15. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    Machino-Ohtsuka T, Seo Y, Ishizu T, Yamamoto M, Hamada-Harimura Y, Machino T, Yamasaki H, Sekiguchi Y, Nogami A, Aonuma K, Ieda M.
    J Cardiol; 2019 Sep 18; 74(3):235-244. PubMed ID: 30910388
    [Abstract] [Full Text] [Related]

  • 16. Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry).
    Kobayashi Y, Omote K, Nagai T, Kamiya K, Konishi T, Sato T, Kato Y, Komoriyama H, Tsujinaga S, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
    Am J Cardiol; 2020 Mar 01; 125(5):772-776. PubMed ID: 31898963
    [Abstract] [Full Text] [Related]

  • 17. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
    Chung S, Kim TH, Uhm JS, Cha MJ, Lee JM, Park J, Park JK, Kang KW, Kim J, Park HW, Choi EK, Kim JB, Kim CS, Lee YS, Shim J, Joung B.
    Am J Cardiol; 2020 Jan 01; 125(1):68-75. PubMed ID: 31699363
    [Abstract] [Full Text] [Related]

  • 18. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction.
    Rusinaru D, Houpe D, Szymanski C, Lévy F, Maréchaux S, Tribouilloy C.
    Eur J Heart Fail; 2014 Sep 01; 16(9):967-76. PubMed ID: 25111982
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P, Chamberlain AM, Hodge DO, Cai C, Xiao PL, Han J, Jiang CY, Redfield MM, Roger VL, Cha YM.
    J Cardiovasc Electrophysiol; 2020 Sep 01; 31(9):2275-2283. PubMed ID: 32584498
    [Abstract] [Full Text] [Related]

  • 20. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A, Saad M, Saksena S.
    J Interv Card Electrophysiol; 2019 Sep 01; 55(3):325-331. PubMed ID: 30887281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.